期刊文献+

家族性乳腺癌与散发性乳腺癌临床生物学特性分析 被引量:2

Analysis of the clinical and molecular biological characteristics of familial and sporadic breast cancer
原文传递
导出
摘要 目的比较家族性乳腺癌与散发性乳腺癌的临床和分子生物学特性,探讨家族性乳腺癌的临床特点和预后。方法回顾性分析河北医科大学第四医院外科2005年6月至2006年5月收治的681例乳腺癌患者的临床资料,其中家族性乳腺癌18例,散发性乳腺癌663例,比较两组间临床生物学行为特点。结果家族性乳腺癌的组织学分级Ⅲ级比例(44.4%)明显高于散发性乳腺癌(17.2%),两组间差异有统计学意义(χ2=9.943,P=0.007);家族性乳腺癌的ER阴性率(50.0%)高于散发性乳腺癌(27.0%),两组间差异有统计学意义(χ2=6.203,P=0.045);家族性乳腺癌的VEGF表达阳性率(44.4%)高于散发性乳腺癌(21.9%),两组间差异有统计学意义(χ2=6.783,P=0.034)。但家族性乳腺癌和散发性乳腺癌患者在年龄分布(χ2=0.505,P=0.918),绝经状况(χ2=0.915,P=0.633),肿瘤大小(χ2=1.595,P=0.660),临床分期(χ2=1.882,P=0.597),病理类型(χ2=2.430,P=0.876),腋淋巴结转移率(χ2=0.999,P=0.607),PR(χ2=3.088,P=0.214)及C-erbB-2表达(χ2=3.094,P=0.213)等方面的差异均无统计学意义。结论家族性乳腺癌的组织学分级、ER阴性率、VEGF表达阳性率均明显高于散发性乳腺癌,提示预后较差。 Objective To compare the clinical and molecular biological characteristics between familial and sporadic breast cancer, and investigate the clinical characteristics and prognosis of familial breast cancer. Methods The clinical data of 681 breast cancer patients who were treated in the Fourth Affiliated Hospital of Hebei Medical University between June 21305 and May 2006 were retrospectively analyzed, 18 of them were familial breast cancer and 663 were sporadic. The clinical biological differences were compared between the two groups. Results The comparison of familial with sporadic breast cancer patients showed the rate of histological grading Ⅲ (44.4%), the rate of ER negative breast cancer (50.0%), and the expression of VEGF (44.4%) were all higher in the familial breast cancer than those ( 17. 2%, 27.0%, and 21.9% ) in the sporadic breast cancer, with statistic differences [ Х^2 = 9.943, P=0. 007), Х^2 =6.203, P =0.045), and Х^2 =6.783, P=0.034)] respectively between the two groups. No significant differences were found in age, menopause state, tumor size, pathology type, metastatic rate of axillary lymph nodes, clinical stage, PR and C-erbB-2. Conclusion Familial breast cancer has a higher histological grading, lower expression of ER and higher expression of VEGF, which indicates a bad prognosis.
出处 《中华乳腺病杂志(电子版)》 CAS 2007年第4期98-101,共4页 Chinese Journal of Breast Disease(Electronic Edition)
基金 河北省医学适用技术跟踪项目(GL200520)
关键词 乳腺肿瘤 家族性 生物学行为 Breast neoplasms Familial Biological behavior
  • 相关文献

参考文献13

二级参考文献30

  • 1阚秀 赵蕊 等.国人与美、日等国妇女乳腺癌的临床病理对比[J].中国肿瘤临床,1987,14:262-5.
  • 2野水整 柿沼雄二 等.癌家族历上乳癌.第四届日本乳癌学会总会论文摘要[M].,1996,6(26)..
  • 3Mohammed S N,Smith P,Hodgson S N,et al.Family history and survival in premenopausal breast cancer[J].BrJ Cancer,1998,77(12):2252-2256.
  • 4Eccles D,Simmonds P,Goddard T,et al.Familial Breast Cancer:an investigation into the outcome of treatment for early stage disease[J].Fam Cancer,2001,1 (2):65-72.
  • 5陈灿明.乳腺癌病理学进展[A].沈镇宙,邵志敏.现代乳腺肿瘤学进展[C].上海:上海科学技术文献出版社,2004:56-78.
  • 6Tada T,Kasumi F.Characteristics of familial breast cancer[J].Nippon Riusho,2000,58(7):1405-1408.
  • 7Geoffrey L R.Predisposition of breast cancer[A].Kelly K H,Geoffrey L R.Breast Cancer[C].New York:Springer-Verlag New York Inc,2001:55-92.
  • 8Takayuki K,Takashi F,Akashi S,et al.Prognosis of breast cancer patients with familial history classified acorrding to their menopausal status[J].Breast J,2004,10(3):218-221.
  • 9Fukutomi T,Akashi-Tanaka S.Differnces in the progesteronr receptor contents between familial breast cancer and sporadic breast cancer stratified by patient age[J].Surg Today,2001,31(1):963-967.
  • 10Dumitrescu R G,Cotarla I.Understanding breast cancer riskwhere do we stand in 2005?[J].J Cell Mol Med,2005,9(1):208-221.

共引文献18

同被引文献16

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部